GREY:NEPTF - Post by User
Post by
Intuitx2on Nov 27, 2019 5:22pm
59 Views
Post# 30399855
NEPT already submitted clinical data to FDA via SugarLeaf
NEPT already submitted clinical data to FDA via SugarLeaf 1) NEPT has clearly stated, Quebec facility is THC only, North Carolina facility is CBD only
2) NEPT signed an agreement with Tetra Bio Pharma almost 2 years ago...read below again
3) Human clinical trials for NEPT are done by outside sources (Tetra Bio Pharma) per NEPT Investor Relations call back to me
4) This gives SugarLeaf the human clinical data for the FDA in the U.S.
5) It shows the game plan for SugarLeaf acquisition was planned WAY IN ADVANCE
LAVAL, QUBEC--(Marketwired - Feb. 12, 2018) - Tetra Bio-Pharma Inc. ("Tetra") (TSX VENTURE:TBP)(OTCQB:TBPMF) and Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ:NEPT)(TSX:NEPT) today announced that they entered into an agreement for the co-development, commercialization and marketing of purified cannabinoid oil-based products to address pain and inflammation relief applications for the natural health products and pet veterinary markets.
Imho, NEPT shorts should be called wh0res, because they're so easy to f k.